Gene · 10280
Papers1,549
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,549
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The protective effect of DMT against neurodegeneration. | Int Rev Neurobiol | 2025 | 40541317 | PubTator, text mining | PubMed |
| Mitochondria-Associated Membranes: A Key Point of Neurodegenerative Diseases. | CNS Neurosci Ther | 2025 | 40406921 | PubTator, text mining | PubMed |
| DRBP-EDP: classification of DNA-binding proteins and RNA-binding proteins using ESM-2 and dual-path neural network. | NAR Genom Bioinform | 2025 | 40391089 | PubTator, text mining | PubMed |
| Identification and verification of a polyamine metabolism-related gene signature for predicting prognosis and immune infiltration in osteosarcoma. | J Orthop Surg Res | 2025 | 40383808 | PubTator, text mining | PubMed |
| Synthesis and in vivo biological characterization of six carbon-11 sigma-1 receptor radiotracers in rodent and nonhuman primate. | Bioorg Med Chem | 2025 | 40339216 | PubTator, text mining | PubMed |
| Mechanism of S-Palmitoylation in Polystyrene Nanoplastics-Induced Macrophage Cuproptosis Contributing to Emphysema through Alveolar Epithelial Cell Pyroptosis. | ACS Nano | 2025 | 40335889 | PubTator, text mining | PubMed |
| A novel SIGMAR1 missense mutation leads to distal hereditary motor neuropathy phenotype mimicking juvenile ALS: a case report of China. | Front Genet | 2025 | 40309037 | PubTator, text mining | PubMed |
| In silico-based analysis and in vitro experiments identify SIGMAR1 as a potential marker of putative lung cancer stem cells. | Discov Oncol | 2025 | 40285994 | PubTator, text mining | PubMed |
| Recent Advances in the Development of Sigma Receptor (Radio)Ligands and Their Application in Tumors. | ACS Pharmacol Transl Sci | 2025 | 40242588 | PubTator, text mining | PubMed |
| The application value of multimodal ultrasound imaging technology in the prediction of early-stage type 2 diabetic kidney disease. | Sci Rep | 2025 | 40216906 | PubTator, text mining | PubMed |
| SIGMAR1 screened by a GPCR-related classifier regulates endoplasmic reticulum stress in bladder cancer. | J Transl Med | 2025 | 40211230 | PubTator, text mining | PubMed |
| The astrocytic sigma-1 receptor constitutes in the fast antidepressant action of hypidone hydrochloride (YL-0919) in rodents. | Front Pharmacol | 2025 | 40206084 | PubTator, text mining | PubMed |
| Mutated sigma-1R disrupts cell homeostasis in dHMN patient cells. | Cell Mol Life Sci | 2025 | 40202561 | PubTator, text mining | PubMed |
| Sigma-1 Receptor Rescues Autophagy Through AMPK/mTOR Signaling Pathway in Sepsis-Induced Acute Kidney Injury. | Int J Gen Med | 2025 | 40201929 | PubTator, text mining | PubMed |
| Exploring the Relationship Between Antipsychotic Drug Target Genes and Epilepsy: Evidence From Food and Drug Administration Adverse Event Reporting System Database and Mendelian Randomization. | Brain Behav | 2025 | 40170563 | PubTator, text mining | PubMed |
| Targeting HINT1 to improve synaptic plasticity: toward loganin as a new antidepressant strategy. | Mol Psychiatry | 2025 | 40133424 | PubTator, text mining | PubMed |
| Monoamine neurotransmitter-related gene-based genome-wide association study of low-dose ketamine in patients with treatment-resistant depression. | J Psychopharmacol | 2025 | 40129096 | PubTator, text mining | PubMed |
| MicroRNA signature of lymphoblasts from amyotrophic lateral sclerosis patients as potential clinical biomarkers. | Neurobiol Dis | 2025 | 40097075 | PubTator, text mining | PubMed |
| HDAC/σ1R Dual-Ligand as a Targeted Melanoma Therapeutic. | Pharmaceuticals (Basel) | 2025 | 40005993 | PubTator, text mining | PubMed |
| Sigma-1 Receptor-Mediated High Mobility Group A1 Silencing Alleviates Endoplasmic Reticulum Stress-Induced Ovarian Granulosa Cell Apoptosis: An In Vitro Cell Experimental Study. | BJOG | 2025 | 39992005 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10280/papers?page=5